Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach A Cuadrado, G Manda, A Hassan, MJ Alcaraz, C Barbas, A Daiber, ... Pharmacological reviews 70 (2), 348-383, 2018 | 629 | 2018 |
From single drug targets to synergistic network pharmacology in ischemic stroke AI Casas, AA Hassan, SJ Larsen, V Gomez-Rangel, M Elbatreek, ... Proceedings of the National Academy of Sciences 116 (14), 7129-7136, 2019 | 205 | 2019 |
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype MH Elbatreek, S Sadegh, E Anastasi, E Guney, C Nogales, T Kacprowski, ... PLoS biology 18 (11), e3000885, 2020 | 42 | 2020 |
Towards FAIR protocols and workflows: the OpenPREDICT use case R Celebi, JR Moreira, AA Hassan, S Ayyar, L Ridder, T Kuhn, ... PeerJ computer science 6, e281, 2020 | 23 | 2020 |
Towards FAIR protocols and workflows: The OpenPREDICT case study R Celebi, JR Moreira, AA Hassan, S Ayyar, L Ridder, T Kuhn, ... arXiv preprint arXiv:1911.09531, 2019 | 4 | 2019 |
Un-biased housekeeping gene panel selection for high-validity gene expression analysis AI Casas, AA Hassan, Q Manz, C Wiwie, P Kleikers, J Egea, MG López, ... Scientific Reports 12 (1), 12324, 2022 | 3 | 2022 |
Why the way we define diseases prevents innovation and precision medicine ZM Mamdouh, E Anastasi, AA Hassan, J Boltze, MH Elbatreek, C Nogales, ... DrugRxiv, 2023 | | 2023 |
Network pharmacology-based therapy for ischemic stroke: A new concept of medicine AI Casas, A Hassan, J Baumbach, C Kleinschnitz, H Schmidt EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 51, 122-122, 2021 | | 2021 |
FAIR and bias-free network modules for mechanism-based disease redefinitions AAAM Hassan | | 2021 |